Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema

T. Conlon (Munich, Germany)

Source: ERS Lung Science Conference 2016
Number: 16
Disease area: Airway diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Conlon (Munich, Germany). Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema. ERS Lung Science Conference 2016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
LSC Abstract – Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema
Source: International Congress 2016 – New therapies and therapeutic targets
Year: 2016

Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020

2D cross-omics integrated enrichment analysis reveals insights into COPD pathogenesis
Source: International Congress 2017 – New Mechanistic Findings in COPD
Year: 2017

Recent insights into chronic lung allograft dysfunction using genomics, proteomics and animal models
Source: Annual Congress 2011 - Novelties in lung transplantation
Year: 2011

High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications
Source: Eur Respir J 2009; 33: 489-506
Year: 2009

Application of ’omics technologies to biomarker discovery in inflammatory lung diseases
Source: Eur Respir J 2013; 42: 802-825
Year: 2013

COPD – will new insights into molecular pathology define new therapies?
Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD
Year: 2014

iTRAQ-based proteomic analysis reveals mitochondrial 'damage'-associated molecular patterns are involved in pulmonary inflammation in Lypopolysaccharide-induced acute lung injury
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018

Proteomic and genomic profiling to identify pathogenic mechanisms of inflammation, proteolysis and wasting in a murine COPD model
Source: Eur Respir J 2004; 24: Suppl. 48, 104s
Year: 2004

Gene-set analysis of lung samples provides insight into pathogenesis of progressive, fibrotic pulmonary sarcoidosis
Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms
Year: 2010

Development of an integrative approach to identify key molecular targets involved in bleomycin-induced pulmonary fibrosis in rats.
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017

Metabolomic profiling of clinical sputum samples reveals novel biomarkers for the early identification of lung cancer patients
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

The landscape of transcriptomic and proteomic studies in sarcoidosis
Source: ERJ Open Res, 8 (1) 00621-2021; 10.1183/23120541.00621-2021
Year: 2022

Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease”
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009

Imaging and molecular biomarkers: a novel approach to screen populations at risk of pulmonary fibrosis?
Source: Eur Respir J 2016; 48: 1271-1273
Year: 2016

Comparative analysis of the plasma metabolomics in rodent models of pulmonary hypertension and patients with IPAH shows different metabolic signatures
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019

“Integrative microbiomics” reveals a disrupted interactome in bronchiectasis exacerbations
Source: Virtual Congress 2020 – Bronchiectasis: epidemiology, endotyping and therapy
Year: 2020

N-ethyl-N-nitrosourea mutagenesis: a new tool for exploring lung disease
Source: Annual Congress 2010 - Scientific Year in Review
Year: 2010

Interference RNA as a new tool and possible future therapy for inflammatory lung disease
Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes
Year: 2005

High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013